Printer Friendly

Browse Pulmonary fibrosis topic

 

Articles

1-284 out of 284 article(s)
Title Author Type Date Words
UK MHRA Grants Prometic PIM Designation for PBI-4050 in Treatment of Idiopathic Pulmonary Fibrosis. Dec 12, 2017 342
United States : Global Blood Therapeutics Announces Discontinuation of Idiopathic Pulmonary Fibrosis (IPF) Program. Oct 30, 2017 445
Prometic awarded US FDA's Fast Track Designation for PBI-4050 for Idiopathic Pulmonary Fibrosis. Oct 26, 2017 244
Prometic awarded US FDA's Fast Track Designation for PBI-4050 for Idiopathic Pulmonary Fibrosis. Oct 26, 2017 240
Prometic Receives Fast Track Designation for PBI-4050 in Development for Idiopathic Pulmonary Fibrosis (IPF). Oct 25, 2017 1044
Global Idiopathic Pulmonary Fibrosis Market Expected to Reach $3,569 Million by 2023 - Allied Market Research. Oct 12, 2017 810
Global Idiopathic Pulmonary Fibrosis Market Expected to Reach $3,569 Million by 2023 - Allied Market Research. Oct 12, 2017 816
Pulmonary Fibrosis Walk Surpasses Participation And Fundraising Goals. Sep 29, 2017 344
Speakers Set For International Conference On Pulmonary Fibrosis. Conference news Sep 27, 2017 766
Prometic passes US FDA clearance to initiate pivotal PBI-4050 Phase 2/3 trial in patients with idiopathic pulmonary fibrosis in the US. Sep 26, 2017 335
American Lung Association stepping up the fight against lesser known Idiopathic Pulmonary Fibrosis, or IPF. Sep 21, 2017 947
PMD Heatlhcare Supports Pulmonary Fibrosis Month. Sep 11, 2017 508
Idiopathic Pulmonary Fibrosis: A Systemic Disease?. Man, Luo; Hong, Peng Report Sep 1, 2017 1460
Inaugural PFF Walk Kicks Off Pulmonary Fibrosis Awareness Month In September. Aug 1, 2017 648
Pulmonary Fibrosis Foundation Appoints Health Care Advocacy Executive William T. Schmidt As President And CEO. Jul 25, 2017 557
Interstitial Pneumonia With Autoimmune Features: Value of Histopathology. Adegunsoye, Ayodeji; Oldham, Justin M.; Valenzi, Eleanor; Lee, Cathryn; Witt, Leah J.; Chen, Lena; M Jul 1, 2017 6512
Pulmonary Fibrosis Community Lobbies Lawmakers To Support Federal Funding. Jun 15, 2017 646
Global Idiopathic Pulmonary Fibrosis Partnering 2010 to 2017. May 24, 2017 751
Veracyte Announces Clinical Validation Data Demonstrating Envisia(TM) Genomic Classifier's Performance in Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2017. May 23, 2017 1185
Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017. May 10, 2017 1727
Three Lakes Partners and MATTER Announce $1 Million Healthcare Challenge to Drive Quality-of-Life Solutions for People Living With Idiopathic Pulmonary Fibrosis (IPF). Apr 27, 2017 1504
Global Idiopathic Pulmonary Fibrosis Partnering 2010 to 2017. Apr 25, 2017 738
International Pulmonary Fibrosis Community To Gather In Nashville For Biennial Global Summit, Nov. 9-11, 2017. Apr 19, 2017 639
Pulmonary fibrosis caused by failure of lung-repair stem cells. Dec 5, 2016 528
Interobserver Agreement of Usual Interstitial Pneumonia Diagnosis Correlated With Patient Outcome. Hashisako, Mikiko; Tanaka, Tomonori; Terasaki, Yasuhiro; Uekusa, Toshimasa; Achcar, Rosane D.; Aswad Dec 1, 2016 4261
Global Idiopathic Pulmonary Fibrosis Drugs Price Strategies Report 2016: How the Price Advanced from 2012 and Forecast to 2021 - Research and Markets. Nov 18, 2016 459
Global Idiopathic Pulmonary Fibrosis Drugs Price Strategies Report 2016: How the Price Advanced from 2012 and Forecast to 2021 - Research and Markets. Nov 18, 2016 499
ProMetic's PBI-4050 Demonstrates Early Evidence of Efficacy in its Idiopathic Pulmonary Fibrosis ("IPF") Phase 2 Clinical Trial. Nov 17, 2016 1447
Idiopathic Pulmonary Fibrosis Pipeline Landscape and Therapeutics Market Review H2 2016. Nov 13, 2016 1056
Idiopathic Pulmonary Fibrosis Pipeline Landscape and Therapeutics Market Review H2 2016. Nov 13, 2016 1060
Chicago Bear Jordan Howard Brings His Fight To Pulmonary Fibrosis. Nov 7, 2016 622
Framework For The Provision Of Medicinal Products For Human Use For The Treatment Of Idiopathic Pulmonary Fibrosis Agreement. Oct 26, 2016 200
Framework For The Provision Of Medicinal Products For Human Use For The Treatment Of Idiopathic Pulmonary Fibrosis Agreement. Oct 6, 2016 198
Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAs. Yang, Cui; Zheng, Si-Dao; Wu, Hong-Jin; Chen, Shao-Jun Report Oct 5, 2016 5753
Patara Pharma Announces Positive Phase 2 Results for the Treatment of Refractory Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis. Financial report Sep 7, 2016 788
Boehringer Ingelheim and Duke Clinical Research Institute Expand Collaboration to Create Largest Patient Registry for Idiopathic Pulmonary Fibrosis (IPF). Aug 25, 2016 1198
Silicosis with progressive massive fibrosis: a case report. Anjali; Dubey, Anuranjan; Singh, Gyanendra Narayan; Verma, Anjali; Prasad, Vijay Shankar Clinical report Aug 15, 2016 849
Secreted phosphoprotein 1 and sex-specific differences in silica-induced pulmonary fibrosis in mice. Latoche, Joseph D.; Ufelle, Alexander Chukwuma; Fazzi, Fabrizio; Ganguly, Koustav; Leikauf, George D Report Aug 1, 2016 7677
Niche Fibrosis: Identification of regulatory signals from vascular niche in alveolar regeneration and pulmonary fibrosis. Jul 28, 2016 380
Idiopathic Pulmonary Fibrosis Market 2025 Epidemiology Forecasts. Jul 26, 2016 931
Idiopathic Pulmonary Fibrosis Market 2025 Epidemiology Forecasts. Jul 26, 2016 937
"EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2025" Published. Jul 15, 2016 538
US led Idiopathic Pulmonary Fibrosis Treatment Industry in 7MM Epidemiology Forecast to 2025. Jul 14, 2016 743
Market Report, "Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016", published. Report Jul 6, 2016 535
Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Idiopathic Pulmonary Fibrosis. Jun 20, 2016 1179
Global Blood Therapeutics begins Phase 2a Study of GBT440 in idiopathic pulmonary fibrosis patients. Jun 20, 2016 316
Global Blood Therapeutics begins Phase 2a Study of GBT440 in idiopathic pulmonary fibrosis patients. Jun 20, 2016 312
Boehringer Ingelheim collaborates with Inventiva on development of potential new treatments for idiopathic pulmonary fibrosis. Jun 1, 2016 267
Boehringer Ingelheim collaborates with Inventiva on development of potential new treatments for idiopathic pulmonary fibrosis. Jun 1, 2016 263
Market Report, "Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016", published. May 31, 2016 479
Global Idiopathic Pulmonary Fibrosis 2016-2020 - Increased Use of Off-Label and Alternative Therapies is a Market Challenge - Research and Markets. May 23, 2016 1018
Global Idiopathic Pulmonary Fibrosis 2016-2020 - Increased Use of Off-Label and Alternative Therapies is a Market Challenge - Research and Markets. May 23, 2016 1058
Global Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights 2016 - Research and Markets. May 5, 2016 519
Global Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights 2016 - Research and Markets. May 5, 2016 559
Data from Multiple Studies Evaluating Veracyte's Genomic Classifiers for Lung Cancer and Idiopathic Pulmonary Fibrosis to Be Presented at ATS 2016. May 3, 2016 2107
Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo. Qu, Yubei; Zhang, Guanghua; Ji, Yunxia; Zhua, Haibo; Lv, Changjun; Jiang, Wanglin Report Apr 15, 2016 6337
Pulmonary Fibrosis Foundation Launches National Registry For Pulmonary Fibrosis Patients, Enrolls First Patient. Apr 7, 2016 1127
Broadway Stars, Tony And Grammy Winners, Take The Stage To Raise Funds And Awareness For The Pulmonary Fibrosis Foundation. Mar 10, 2016 1309
Update on Pulmonary Fibrosis: Not All Fibrosis Is Created Equally. Smith, Maxwell L. Mar 1, 2016 5603
Galectin Therapeutics wins US patent allowance for GR-MD-02 for pulmonary fibrosis. Feb 25, 2016 203
Galectin Therapeutics wins US patent allowance for GR-MD-02 for pulmonary fibrosis. Feb 25, 2016 199
Market Report, "Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2015", published. Report Jan 20, 2016 480
Just Published: "Pulmonary Fibrosis - Pipeline Review, H2 2015". Jan 18, 2016 473
First Multinational Study Initiated to Evaluate OFEV (nintedanib) with Add-on of pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis. Dec 14, 2015 1868
Pulmonary Fibrosis Foundation Care Center Network Adds 19 New Sites. Dec 1, 2015 1074
Pulmonologists Report High Unmet Need For New Products To Treat Idiopathic Pulmonary Fibrosis (IPF), Despite The Recent Launches Of Roche's Esbriet And Boehringer Ingelheim's Ofev. Nov 30, 2015 465
Pulmonary Fibrosis Foundation Acquires Daughters of Pulmonary Fibrosis Programme. Nov 20, 2015 370
Pulmonary Fibrosis Foundation Acquires Daughters of Pulmonary Fibrosis Programme. Nov 20, 2015 385
Pulmonary Fibrosis Foundation Acquires Daughters of Pulmonary Fibrosis Program to Continue Inspiring Local Awareness Efforts and Serve the Community. Nov 19, 2015 752
Pulmonary Fibrosis Foundation International Conference A Forum For Sharing Research, Launching New Programs. Conference notes Nov 18, 2015 1145
Germany : New Analyses Further Add to the Efficacy and Safety Profile of OFEVA (nintedanib) in Idiopathic Pulmonary Fibrosis (IPF). Nov 16, 2015 928
Germany : New Analyses Further Add to the Efficacy and Safety Profile of OFEV (nintedanib) in Idiopathic Pulmonary Fibrosis (IPF). Nov 14, 2015 537
Pulmonary Fibrosis Foundation Highlights Scientific Program at Upcoming Third Biennial International Conference. Conference news Nov 9, 2015 1157
Genentech Named Founding Partner For Pulmonary Fibrosis Foundation Patient Registry Program. Nov 5, 2015 827
Pulmonary Fibrosis Foundation Announces Five Year Partnership With Boehringer Ingelheim To Support Programs Designed To Improve Patient Outcomes. Nov 5, 2015 951
New Results From a Patient Registry Reveal Insights About Idiopathic Pulmonary Fibrosis (IPF). Oct 22, 2015 1260
Prevalence of pulmonary function defects in psoriasis patients receiving methotrexate in a tertiary care hospital in Tamilnadu, India. Vijay, G. Allwyn Report Oct 15, 2015 2885
Keynote Addresses By Respected Experts In Patient Care Among Upcoming Pulmonary Fibrosis Foundation International Conference Program Highlights. Conference news Oct 8, 2015 1241
Pulmonary Fibrosis Foundation Appoints Patti Tuomey, EdD, As President And Chief Executive Officer. Oct 6, 2015 930
Pulmonary Fibrosis Foundation Announces 2015 Research Fund To Cure Pulmonary Fibrosis Award Recipients. Awards list Oct 1, 2015 892
Switzerland : New data will be presented for Roche's Esbriet in idiopathic pulmonary fibrosis at European Respiratory Society Congress 2015. Sep 23, 2015 300
Hope for idiopathic pulmonary fibrosis treatment. Sep 14, 2015 499
MediciNova awarded US FDA Fast Track designation for MN-001 for treating idiopathic pulmonary fibrosis. Sep 11, 2015 238
MediciNova awarded US FDA Fast Track designation for MN-001 for treating idiopathic pulmonary fibrosis. Sep 11, 2015 234
Global Idiopathic Pulmonary Fibrosis Partnering 2010-2015. Sep 7, 2015 963
Pulmonary Fibrosis Foundation Celebrates Global Pulmonary Fibrosis Awareness Month To Increase Disease Awareness And Education. Sep 1, 2015 936
The value of bronchoalveolar lavage in the diagnosis and management of specific Ild idiopathic pulmonary fibrosis. Narender, Methuku; Somishetty, Laxmi Kumari; Bhashini, Matta; Rao, Vavilala Satish Kumar; Kumar, Auz Report Aug 24, 2015 2435
Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis. Aug 5, 2015 792
Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis. Aug 5, 2015 753
Boehringer Ingelheim Welcomes the Inclusion of OFEV (nintedanib) in the Updated International Treatment Guidelines for Idiopathic Pulmonary Fibrosis (IPF). Jul 15, 2015 1664
Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis. Yan, Wei; Peng, Li-Ying; Ban, Cheng-Jun; Xu, Xue-Feng; Zhu, Min; Liu, Yan; Zhang, Shu; Zhai, Zhen-Gu Report Jul 1, 2015 4038
Acquired pandigital clubbing. Samuel, Soumya; Kamalakannan, K.; Prasath, P. Arun; Srivenkateswaran, K. Report May 14, 2015 543
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015 - New Study Released. May 11, 2015 553
Isoniazid and Pulmonary Fibrosis. Chung, Chae; Park, Dong; Lee, Choong; Jung, Sung Letter to the editor May 1, 2015 664
Pulmonary Fibrosis Foundation Announces Open Registration And Call For Abstracts For International Conference On Pulmonary Fibrosis. Conference news Apr 28, 2015 1303
Aeolus wins US FDA's orphan drug designation for AEOL 10150 for treating idiopathic pulmonary fibrosis. Mar 18, 2015 218
Aeolus wins US FDA's orphan drug designation for AEOL 10150 for treating idiopathic pulmonary fibrosis. Mar 18, 2015 214
Pulmonary Fibrosis Foundation Expands Funding For Support Groups Across The Country. Mar 12, 2015 927
HealthWell Foundation Now Offers Copayment Assistance To Pulmonary Fibrosis Patients. Mar 10, 2015 641
ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis. Disease/Disorder overview Mar 5, 2015 716
Now Available: Pulmonary Fibrosis - Pipeline Review, H1 2015. Mar 2, 2015 417
Broadway Stars Show Off Their Belting Talents To Raise Funds And Awareness For The Pulmonary Fibrosis Foundation. Feb 24, 2015 1167
New Survey Uncovers Emotional and Physical Impact of Idiopathic Pulmonary Fibrosis, a Fatal Lung Disease. Feb 12, 2015 1583
Pulmonary Fibrosis Foundation Announces Expansion Of First-Of-Its-Kind Care Center Network. Jan 27, 2015 906
Pulmonary Fibrosis Therapeutics Pipeline H2 2014 Review Market Research Report. Jan 21, 2015 1348
Pulmonary Fibrosis Therapeutics Pipeline H2 2014 Review Market Research Report. Jan 21, 2015 1342
Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats. Li, Liucheng; Li, Delin; Xu, Liang; Zhao, Ping; Denga, Ziyu; Mo, Xiaoting; Li, Ping; Qi, Lianwen; Li Report Jan 15, 2015 6058
Nintedanib* Receives Positive CHMP Opinion in European Union for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). Nov 24, 2014 2474
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014 - New Study Released. Report Nov 12, 2014 549
Scleroderma Research Foundation to Host Live Webinar on Pulmonary Fibrosis. Nov 7, 2014 674
Pulmonary Fibrosis Foundation Applauds The Food And Drug Administration's (FDA) Prompt Decision To Approve Esbriet (pirfenidone) And OFEV (nintedanib) For The Treatment Of Idiopathic Pulmonary Fibrosis. Oct 16, 2014 909
United States : FDA approves Ofev to treat idiopathic pulmonary fibrosis. Oct 16, 2014 362
United States : FDA approves Esbriet to treat idiopathic pulmonary fibrosis. Oct 16, 2014 363
FDA Approves Boehringer Ingelheim's OFEV (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis. Oct 15, 2014 2956
Setback in treatment for IPF patients. Brief article Oct 1, 2014 264
InterMune Supports Launch of First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF) in European Parliament. Sep 30, 2014 1563
Boehringer Ingelheim Statement on FDA Drug Development Public Meeting for Idiopathic Pulmonary Fibrosis (IPF). Sep 26, 2014 430
'No better than cancer ... it's a death sentence' Wife of tragic pulmonary fibrosis victim describes the impact on both of their lives. Sep 20, 2014 849
PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting. Sep 16, 2014 1146
Analyses of Pooled Data from Three Phase III Trials of Pirfenidone (Esbriet[,u-]) Show a Favourable and Persistent Treatment Benefit on Disease Progression in Patients with Idiopathic Pulmonary Fibrosis up to 72 weeks. Sep 9, 2014 2303
September Is Global Pulmonary Fibrosis Awareness Month. Sep 2, 2014 1292
Sorrento secures NIH grant to advance WISP1 in the Idiopathic Pulmonary Fibrosis programme. Aug 27, 2014 242
Sorrento secures NIH grant to advance WISP1 in the Idiopathic Pulmonary Fibrosis programme. Aug 27, 2014 238
Pulmonary Fibrosis Foundation's Patient Survey To Reveal New Insights. Aug 14, 2014 1065
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 594
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 599
Moerae Matrix Initiates Phase 1 Clinical Trial of MMI-0100, a First-in-Class Inhibitor of MK2, for Treatment of Idiopathic Pulmonary Fibrosis. Aug 5, 2014 611
Moerae Matrix Initiates Phase 1 Clinical Trial of MMI-0100, a First-in-Class Inhibitor of MK2, for Treatment of Idiopathic Pulmonary Fibrosis. Aug 5, 2014 617
Pulmonary Fibrosis Foundation Launches National PFF Ambassador Program. Jul 23, 2014 1094
Pulmonary Fibrosis Foundation Disease Education Webinars Focus On Pulmonary Rehabilitation And The FDA's Breakthrough Drug Therapy Designation. Jul 21, 2014 739
U.S. FDA Accepts NDA Filing for Boehringer Ingelheim's Investigational Nintedanib and Grants Priority Review Designation for the Treatment of Idiopathic Pulmonary Fibrosis. Jul 2, 2014 878
Boehringer Ingelheim Announces Nintedanib Expanded Access Program (EAP) for Patients with Idiopathic Pulmonary Fibrosis. Jun 24, 2014 902
The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry. Jun 10, 2014 877
InterMune resubmits pirfenidone's NDA to the US FDA for treating idiopathic pulmonary fibrosis in adults. May 28, 2014 240
InterMune resubmits pirfenidone's NDA to the US FDA for treating idiopathic pulmonary fibrosis in adults. May 28, 2014 244
Veracyte unveils early data for molecular classifier for idiopathic pulmonary fibrosis diagnosis. May 21, 2014 193
InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary Fibrosis. May 20, 2014 3224
Pulmonary Fibrosis Foundation Offers Clinical Trial Update Webinar. May 18, 2014 779
Phase 3 INPULSIS(TM) Trials Published in the New England Journal of Medicine Show Investigational Nintedanib Slowed Lung Function Loss in People with Idiopathic Pulmonary Fibrosis. May 18, 2014 2122
Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine. Clinical report May 18, 2014 3462
Pulmonary Fibrosis Foundation Provides The Latest Disease Education Information. May 16, 2014 710
Pulmonary Fibrosis Foundation Announces New Programs, Redesigned Website. Website overview May 14, 2014 1041
Pulmonary Fibrosis Foundation Launches First Communication Center For The Pulmonary Fibrosis Community. Mar 27, 2014 759
InterMune Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF). Feb 28, 2014 1096
Broadway's Finest Gather To Raise Funds And Awareness For The Pulmonary Fibrosis Foundation. Feb 26, 2014 1358
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF). Feb 25, 2014 2917
Pulmonary Fibrosis Foundation Expands With Two New Leadership Positions. Feb 4, 2014 1291
Boehringer Ingelheim and Duke Clinical Research Institute Form Collaborative Partnership to Study the Natural History of Idiopathic Pulmonary Fibrosis (IPF). Jan 30, 2014 1018
Sanofi, MAbImprove LabEx to develop aerosol antibody formulation for idiopathic pulmonary fibrosis. Jan 27, 2014 165
FibroGen begins patient enrolment for Phase II clinical trial of FG-3019 in patients with idiopathic pulmonary fibrosis. Dec 24, 2013 146
FibroGen begins patient enrolment for Phase II clinical trial of FG-3019 in patients with idiopathic pulmonary fibrosis. Dec 24, 2013 142
The Pulmonary Fibrosis Community Again Commends The Pulmonary Fibrosis Foundation's Biennial PFF Summit. Dec 17, 2013 1284
Pulmonary Fibrosis Foundation Announces Plans To Establish A Care Center Network And Patient Registry. Dec 10, 2013 1659
InterMune Announces Support of The Pulmonary Fibrosis Foundation Care Center Network and Patient Registry Initiative. Dec 10, 2013 1325
Childhood idiopathic interstitial pneumonia: diagnosis, treatment and follow-up. Cinel, Guzin; Gulhan, Bora; Kiper, Nural; Yalcin, Ebru; Dogru, Deniz; Ozcelik, Ugur; Orhan, Dicle Report Dec 1, 2013 4989
Pulmonary Fibrosis Foundation Raises Funds and Awareness While Recognizing Outstanding Leaders in the Pulmonary Fibrosis Community. Nov 8, 2013 1696
Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation. dos Santos, G.C.; Parra, E.R.; Stegun, F.W.; Cirqueira, C.S.; Capelozzi, V.L. Report Nov 1, 2013 4885
Coalition for Pulmonary Fibrosis Announces First Ever Daughters of Pulmonary Fibrosis Leadership Conference. Conference news Oct 9, 2013 968
Actress Rose McGowan Collaborates with Boehringer Ingelheim and the Coalition for Pulmonary Fibrosis to Raise Awareness of Idiopathic Pulmonary Fibrosis -- a Rare Lung Disease with which her Father Was Diagnosed. Sep 24, 2013 1581
Idiopathic pulmonary fibrosis (IPF) community emphasizes the power of united support for patients during IPF World Week 2013. Sep 20, 2013 1401
Pulmonary Fibrosis Foundation Announces Second Annual Global Pulmonary Fibrosis Awareness Day. Aug 16, 2013 1599
New Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2013. Jun 14, 2013 462
Genoa Pharmaceuticals and McMaster University demonstrate in vivo benefit of inhaled pirfenidone offering greater pulmonary fibrosis efficacy than oral therapy. Jun 5, 2013 665
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 201. May 30, 2013 552
Genetic risk factor for pulmonary fibrosis identified. May 22, 2013 295
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017. May 14, 2013 2585
EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022. Report Apr 22, 2013 1267
7 new genes behind pulmonary fibrosis identified. Apr 20, 2013 258
Veerappan proves Mast Cells have critical role in initializing Pulmonary Fibrosis. Apr 17, 2013 580
Pulmonary Fibrosis Foundation Announces Open Registration For International Health Care Conference On Pulmonary Fibrosis. Conference news Mar 27, 2013 1156
Esbriet (pirfenidone) Receives Positive Final Appraisal Determination from NICE for Idiopathic Pulmonary Fibrosis (IPF). Mar 20, 2013 1556
Broadway's Best Gather to Raise Funds and Awareness for the Pulmonary Fibrosis Foundation. Feb 26, 2013 1218
Research and Markets: Pulmonary Fibrosis - Pipeline Review, H2 2012. Feb 8, 2013 366
Genoa Pharmaceuticals and McMaster University to collaborate on Idiopathic Pulmonary Fibrosis Research. Jan 16, 2013 521
Coalition for Pulmonary Fibrosis Joins Centers for Disease Control in Spreading Urgent Word to Patients About Important Immunizations, including Flu Shots. Jan 16, 2013 1074
Coalition for Pulmonary Fibrosis Partners with Breathe Support for Online Support Groups to Address Specific Needs, Audiences. Jan 15, 2013 1297
Research and Markets: Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2012. Jan 10, 2013 312
Coalition for Pulmonary Fibrosis Announces 2012 Accomplishments in Research, Advocacy, Awareness Efforts. Dec 27, 2012 1851
Actress Rose McGowan To Appear On TV's The Doctors To Speak Out About Pulmonary Fibrosis, Disease That Killed Her Father. Dec 12, 2012 951
Research and Markets: Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update. Nov 28, 2012 457
Research and Markets: Global Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update. Nov 9, 2012 381
Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients. Leslie, Kevin O.; Cool, Carlyne D.; Sporn, Thomas A.; Curran-Everett, Douglas; Steele, Mark P.; Brow Nov 1, 2012 6460
Coalition for Pulmonary Fibrosis Speaks Out for PF Patients, Families in Public Forums at FDA, PCORI. Oct 31, 2012 861
Research and Markets: Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2012. Oct 23, 2012 396
Pulmonary Fibrosis Foundation Calls For Letters Of Intent For 2013 Young Investigator And Established Investigator Awards. Letter to the editor Oct 23, 2012 1157
Pulmonary Fibrosis Foundation's Global Dinner Raises Funds and Awareness For The Fight Against Pulmonary Fibrosis. Oct 17, 2012 1449
Pathologic quantification of connective tissue disease-associated versus idiopathic usual interstitial pneumonia. Cipriani, Nicole A.; Strek, Mary; Noth, Imre; Gordon, Ilyssa O.; Charbeneau, Jeff; Krishnan, Jerry A Oct 1, 2012 3230
Boehringer Ingelheim Completes Enrollment of Pivotal Phase III Studies for Nintedanib (BIBF 1120) in Idiopathic Pulmonary Fibrosis. Sep 26, 2012 1267
Pulmonary Fibrosis Foundation Announces International Patient Support Group Initiative And Global Pulmonary Fibrosis Awareness Day. Aug 31, 2012 1111
FibroGen's FG-3019 Granted U.S. Orphan Drug Designation for the Treatment of Patients with Idiopathic Pulmonary Fibrosis. Jul 31, 2012 883
Sports Media Celebrities Guy Junker, Stan Savran, Paul Alexander To Co-Host Fundraiser For Pulmonary Fibrosis. Jul 19, 2012 986
Research and Markets: Pulmonary Fibrosis - Pipeline Review, H1 2012. Jul 4, 2012 427
Serum biomarkers for lung disease: biomarkers can play an important role in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases. Torrens, David; Iwata, Ryoichi Report Jul 1, 2012 2293
Pulmonary Fibrosis Foundation Announces Co-Founder Loses Fight Against Idiopathic Pulmonary Fibrosis. Jun 29, 2012 640
MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF). Company overview Jun 20, 2012 1081
Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. Leslie, Kevin O. Jun 1, 2012 5995
Pulmonary Fibrosis Foundation Congratulates Helene Campbell On Her Organ And Tissue Donation Advocacy Efforts. May 24, 2012 886
Pulmonary Fibrosis Foundation Launches Partnership With Inspire Online Support Community. May 14, 2012 1638
FibroGen Announces Promising Preliminary Data from an Open-label Phase 2 Study to Evaluate the Safety and Efficacy of FG-3019 in Individuals with Idiopathic Pulmonary Fibrosis (IPF) and Provides Program Update. May 3, 2012 2664
Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis? Lederer, David J.; Jelic, Sanja; Basner, Robert C.; Bhattacharya, Jahar Letter to the editor May 1, 2012 998
Research and Markets: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2012. Apr 11, 2012 415
September Proclaimed National Pulmonary Fibrosis Awareness Month by Coalition for Pulmonary Fibrosis. Apr 6, 2012 721
Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). Mar 7, 2012 886
Broadway's Best Gather to Raise Funds and Awareness for the Pulmonary Fibrosis Foundation. Feb 28, 2012 1177
The protective effect of Penicillamine against Bleomycine induced pulmonary fibrosis in rats. Mikaili, Peyman; Hemmati, Ali Asghar; Khodayar, Mohammad Javad; Ghafurian, Mehri; Rashidi, Iran Report Jan 1, 2012 2543
Hermansky-Pudlak syndrome complicated by pulmonary fibrosis. Carter, Brett W. Disease/Disorder overview Jan 1, 2012 963
Research and Markets: Pulmonary Fibrosis - Pipeline Review, H2 2011. Dec 19, 2011 402
Pulmonary Fibrosis Foundation's Inaugural IPF Summit Receives High Accolades From Pulmonary Fibrosis Community. Dec 6, 2011 1155
Rehabilitation of patients with Idiopathic pulmonary fibrosis: changes in quality of life, functional mobility, and oxygen metabolism. Dec 1, 2011 551
Idiopathic Pulmonary Fibrosis Drug Market to Grow to $4.6 Billion in 2020. Nov 10, 2011 516
Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful. Brief article Oct 21, 2011 104
Pulmonary Fibrosis Foundation to Fund Further Therapeutic Evaluation Studies for Compugen-Discovered Drug Candidate. Oct 12, 2011 1392
Research and Markets: Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - Keep A Track of Your Competitors and Understand Their Pipeline Molecules. Oct 1, 2011 414
Research and Markets: Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. Sep 16, 2011 396
Lethal Lung Disease -- Pulmonary Fibrosis -- Focus of Nationwide Awareness Efforts. Sep 12, 2011 1170
Pulmonary Fibrosis Research Enhancement Act Re-Introduced in U.S. Congress. Jul 12, 2011 1255
Bi-Partisan Congressional Coalition Reaches Across the Aisle to Introduce the Pulmonary Fibrosis Research Enhancement Act in the U.S. Congress. Jul 12, 2011 906
CPF Announces Dates for National Pulmonary Fibrosis Awareness Week as Part of 10th Anniversary. Jul 5, 2011 947
Long-Time Sports Duo Reunite to Host Fundraiser for Pulmonary Fibrosis. Jun 29, 2011 953
The effective physician: Idiopathic pulmonary fibrosis. Golden, William E.; Hopkins, Robert H. Disease/Disorder overview Jun 15, 2011 712
Modern concepts on the role of inflammation in pulmonary fibrosis. Homer, Robert J.; Elias, Jack A.; Lee, Chun Gun; Herzog, Erica Jun 1, 2011 9462
Promedior Presents Clinical Data for PRM-151 (rhPTX-2) in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2011. Clinical report May 16, 2011 1148
Genetic link found to some pulmonary fibrosis, pneumonia. Moon, Mary Ann May 1, 2011 552
Genetic Discovery Published in New England Journal of Medicine Good News/Bad News for Patients, Families with Pulmonary Fibrosis. Apr 21, 2011 1224
Common genetic variant linked to pulmonary fibrosis risk. Apr 21, 2011 114
Co-Author of Significant National Jewish Health Study on Pulmonary Fibrosis, Dolly Kervitsky, RCP, CCRC, Joins Pulmonary Fibrosis Foundation. Apr 20, 2011 1181
Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis. Apr 19, 2011 474
Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis. Apr 19, 2011 465
Musical Tribute Honoring the Life of Theater Critic Michael Kuchwara, Benefiting the Pulmonary Fibrosis Foundation, Hit High Notes With Liza Minnelli and Broadway Stars. Mar 3, 2011 974
Coalition for Pulmonary Fibrosis Announces New Daughters of PF Program. Feb 28, 2011 796
Coalition for Pulmonary Fibrosis, Pulmonary Fibrosis Foundation and American Thoracic Society Announce New Research Grants for Pulmonary Fibrosis Research. Feb 23, 2011 1856
Promedior Initiates Clinical Study of Anti-Fibrotic Therapeutic, PRM-151, in Patients with Idiopathic Pulmonary Fibrosis (IPF). Feb 10, 2011 892
Promedior Announces Publication of New Research Demonstrating Pentraxin-2/SAP is a Potent Inhibitor of Pulmonary Fibrosis. Feb 10, 2011 1083
FibroGen Announces the Initiation of an Open-label Phase 2 Study to Evaluate the Safety and Efficacy of FG-3019 in Individuals with Idiopathic Pulmonary Fibrosis. Jan 12, 2011 1317
Gilead ends Phase III trial of ambrisentan in idiopathic pulmonary fibrosis. Dec 23, 2010 138
Gilead Terminates Phase III Clinical Trial of Ambrisentan in Patients with Idiopathic Pulmonary Fibrosis. Dec 22, 2010 357
CPF Responds to Positive News on First Drug for Treatment for Pulmonary Fibrosis. Dec 21, 2010 817
Coalition for Pulmonary Fibrosis Achieves Milestones in PF Funding, Advocacy and Awareness. Dec 20, 2010 973
Coalition for Pulmonary Fibrosis Honors Individuals for Their Dedication. Oct 4, 2010 1260
Pulmonary Fibrosis Advocates Increase Co-Sponsors of Research Act Following Lobbying in Washington. Sep 22, 2010 979
8th Annual National Pulmonary Fibrosis Awareness Week Sept. 11-18. Sep 7, 2010 1025
Stromedix Receives FDA Orphan Drug Designation for STX-100 for the Treatment of Idiopathic Pulmonary Fibrosis. Aug 31, 2010 503
Pulmonary Fibrosis Foundation Contributes $200,000 in New Pulmonary Fibrosis Research, Totaling $400,000 in Grants. Aug 30, 2010 990
Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Commitment to Pulmonary Fibrosis Research. Aug 23, 2010 821
Pulmonary Fibrosis Foundation Supports Goals of 2010 National Pulmonary Fibrosis Awareness Week. Aug 19, 2010 982
Pulmonary Fibrosis Research Enhancement Act Introduced in U.S. Senate. Aug 4, 2010 1030
Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis. Fujishima, Seitaro; Shiomi, Takayuki; Yamashita, Shuji; Yogo, Yurika; Nakano, Yasushi; Inoue, Takash Aug 1, 2010 4635
CPF, Advocates Drive Home the Message for Pulmonary Fibrosis. Jul 29, 2010 1111
Research and Markets: Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Market Forecasts to 2017. Jul 22, 2010 590
CPF Announces Dates for Eighth Annual National Pulmonary Fibrosis Awareness Week. Jun 22, 2010 1179
Pulmonary Fibrosis, CPF, to Receive National Media Attention on NBC'S TODAY Show Via California Man's Desperate Fight for Survival. Jun 14, 2010 886
Geron Announces Positive Data on Its Small Molecule Telomerase Activator in Model of Idiopathic Pulmonary Fibrosis. May 19, 2010 728
NeoPharm Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis. May 17, 2010 589
Coalition for Pulmonary Fibrosis Responds to News of Further Review of Pirfenidone By FDA. May 4, 2010 917
Nonneoplastic lung disease--more than just usual interstitial pneumonia. Beasley, Mary Beth Report May 1, 2010 1068
Research and Markets: Idiopathic Pulmonary Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2016. Mar 25, 2010 476
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis. Mar 10, 2010 661
Actelion says BUILD-3 bosentan study in idiopathic pulmonary fibrosis misses primary endpoint. Clinical report Mar 1, 2010 359
Idiopathic pulmonary fibrosis. Wojciechowski, Bill Mar 1, 2010 1269
Lung Rx, ImmuneWorks partner over IW001 in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction. Feb 10, 2010 118
NeoPharm Announces IND Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis. Jan 4, 2010 699
NeoPharm files IND for IL13-PE38QQR for treatment of Idiopathic Pulmonary Fibrosis. Jan 4, 2010 159
Presence of c-KIT-positive mast cells in obliterative bronchiolitis from diverse causes. Fuehrer, Neil E.; Marchevsky, Alberto M.; Jagirdar, Jaishree Report Sep 1, 2009 4402
Pirfenidone may slow deterioration from pulmonary fibrosis. Brunk, Doug Jul 1, 2009 816
Sanko Junyaku Launches Diagnostic Reagent Kit For Automated Clinical Chemistry Analyser To Determine KL-6, Detecting Marker of Interstitial Pneumonia. Jun 2, 2009 774
Compugen Announces Positive Therapeutic Effects of Relaxin Receptor Peptide Ligand in Pulmonary Fibrosis Animal Model. Mar 17, 2009 1151
Talc-induced interstitial pneumonitis with respiratory failure. Griffo, S.; Musumeci, A.; De Luca, G.; Saccenti, A.; Grande, L.M.; Stassano, P. Case study Jan 1, 2009 1765
Pulmonary disease masks lung cancer. Susman, Jeffrey L. Brief article Dec 1, 2008 284
Pirfenidone is promising as pulmonary fibrosis therapy. Walsh, Nancy Clinical report Sep 1, 2008 410
Antiproliferative activity of triterpenoids from Eclipta prostrata on Hepatic stellate cells. Lee, Mi Kyeong; Ha, Na Ry; Yang, Hyekyung; Sung, Sang Hyun; Kim, Gun Hee; Kim, Young Choong Clinical report Sep 1, 2008 3177
High-frequency oscillation ventilation more lung-protective than conventional, very low tidal volume ventilation in a case of pulmonary fibrosis. Friesecke, S.; Abel, P.; Ewert, R. Clinical report Mar 1, 2008 618
NEOPHARM, Inc. Signs Exclusive License Agreement for the Use of CINTREDEKIN BESUDOTOX (IL13-PE38QQR) for the Treatment of Pulmonary Fibrosis and Asthma. Jun 11, 2007 688
N-acetylcysteine slows deterioration in patients with pulmonary fibrosis. Austin, Steve Clinical report Mar 22, 2006 390
Marketing Professionals host event against industry scourge. Brief Article Jan 19, 2005 205
Pulmonary fibrosis. Brief Article Nov 15, 2004 188
Pulmonary fibrosis drugs still lacking. Moon, Mary Ann Brief Article Nov 1, 2004 197
Postmarketing surveillance: leflunomide may be associated with 17 cases of interstitial pneumonia, 6 deaths in Japan. Perlstein, Steve Brief Article Apr 1, 2004 266
Dyspnea and bilateral interstitial pulmonary infiltrates in an intravenous drug user. Jones, Bradley S.; Brancaccio, Frank A.; Rodriguez, Gabriel A. Clinical report Oct 1, 2002 2280
Recurrent spontaneous pneumothorax in an industrial worker. (Pathologic Quiz Case). Strobel, Stephen L. Jun 1, 2002 1009
Fibrosis risks besides alcohol. (Clinical Capsules). Brief Article May 1, 2002 121
Dermatofibrosarcoma protuberans with lung metastasis in a patient with progressive systemic sclerosis. Kisters, Klaus Mar 1, 2002 1518
Congestive Heart Failure in a 25-Year-Old Woman. Wagner, Monica S.; Husain, Aliya N. Sep 1, 2000 973
Facts about idiopathic pulmonary fibrosis. Pamphlet Feb 1, 1993 1995
Pulmonary fibrosis associated with occupational exposure to hard metal at a metal-coating plant - Connecticut, 1989. Jan 31, 1992 1281

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters